Benefits with Every Breath
DUPIXENT was proven to improve lung function and help prevent
asthma attacks in children 6-11 years.
DUPIXENT is not a steroid but can help reduce oral steroid use.
DUPIXENT was studied in a clinical trial with 408 children 6 to 11 years old with uncontrolled moderate-to-severe asthma.
Improved lung function
IN CHILDREN IN AS LITTLE AS
*The annual rate of severe asthma attacks
was 0.24 with DUPIXENT 100mg/200mg
vs 0.67 with placebo.
†Do not stop taking your corticosteroid
medicines unless instructed by your
healthcare provider. This may cause other
symptoms that were controlled by the
corticosteroid medicine to come back.
The safety results of DUPIXENT observed in children through Week 52 were similar to the safety profile from studies in adults and adolescents with moderate-to-severe asthma with the addition of parasitic (helminth) infections.
What You Should Know About the Patients in These Studies:
of attacks in
DUPIXENT had a
profile in clinical trials
The most common side effects include:
- Injection site reactions
- High count of a certain white
blood cell (eosinophilia)
- Pain in the throat
- Parasitic (helminth) infections
HAVE A PRODUCTIVE CONVERSATION WITH YOUR DOCTOR
Personalize your doctor discussion guide
Our goal is for you or your loved one to get the most out of yourvisit to the doctor. Fill out our personalized discussion guide to help you have a productive conversation during your next visit.
frequently asked questions
In clinical trials, the impact of DUPIXENT on lung function was studied in patients 6 to 11 years of age and patients 12 years of age and older. Patients in the DUPIXENT groups saw improved lung function in as little as 2 weeks.
Learn how DUPIXENT helped treat patients 12+ years old with their moderate-to-severe asthma.RESULTS IN PATIENTS
AGES 12+ YEARS